Skip to content
Disclosery

EXANE DERIVATIVES: ADBE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ADBE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,384 ADBE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,384 shares
    Change vs previous 13F -37 shares

    0.29% of the 13F portfolio, value $506,515.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,421 shares
    Change vs previous 13F +14 shares

    0.18% of the 13F portfolio, value $647,387.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,407 shares
    Change vs previous 13F -709 shares

    0.19% of the 13F portfolio, value $797,814.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,116 shares
    Change vs previous 13F -2,279 shares

    0.3% of the 13F portfolio, value $1,218,163.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,395 shares
    Change vs previous 13F +2,209 shares

    0.62% of the 13F portfolio, value $2,658,936.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,186 shares
    Change vs previous 13F -687 shares

    0.31% of the 13F portfolio, value $1,039,096.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,873 shares
    Change vs previous 13F +230 shares

    0.44% of the 13F portfolio, value $1,436,755.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,643 shares
    Change vs previous 13F not available

    0.42% of the 13F portfolio, value $1,296,153.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).